News for Arena Pharmaceuticals, Inc. (0S54.L)

-- Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases -- -- Amit Munshi Appointed Chai

**media[442518]**

-- IkT-001Pro to be developed as a New Molecular Entity as the first oral, potentially disease-modifying treatment for a rapidly fatal disease primarily...

May 24, 2022 / 08:00PM GMTPresentation at Digestive Disease Week CallMay 24, 2022 / 08:00PM GMT =====================Corporate Participants=====================

Longboard Pharmaceuticals, Inc. shares have surged in 2024 due to positive mid-stage trial data. Click here for more on the LBPH stock prospects.

WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split...

Sun Pharma, Dr. Reddy's, Lupin, Torrent, and Zydus Cadila progressing obesity drug candidates in response to rising demand. Notable developments include Sun Pharma's Phase 1 studies and Dr. Reddy’s Laboratories' permission for a semaglutide bioequivalence study

Pharma companies have yet to provide investors with convincing post-pandemic strategies. Read more.

Acumen Research and Consulting recently published report titled “Anti-Obesity Drugs Market Forecast, 2023 - 2032”...

WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- In a major achievement, Avalo Therapeutics (Nasdaq: AVTX) proudly announces the payoff...

/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced that Laurie Stelzer, Chief Financial...

The prevalence of obesity around the world has boosted the need for efficient therapies and drugs, including anti-obesity drugs. Pharmaceutical...

Newark, New Castle, USA, April 10, 2023 (GLOBE NEWSWIRE) -- According to a recent Growth Plus Reports assessment, the anti-obesity drugs market is...

According to Market.us, The Dermatophytic Onychomycosis Treatment Market Is Encouraged to Reach USD 9,801 million by 2032, Revenue to Index 8.46% CAGR Over...

bhvn-20220923 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ... | September 23, 2022

GuruFocus Article or News written by GuruFocusNews and the topic is about:

NEW YORK, Jan. 14, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC , a national securities firm rated Top... | January 15, 2022

Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping...

Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to ...